ARDX logo

Ardelyx (ARDX) Company Overview

Profile

Full Name:

Ardelyx, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

June 19, 2014

Indexes:

Not included

Description:

Ardelyx, Inc. is a biopharmaceutical company focused on developing innovative treatments for kidney and gastrointestinal diseases. They aim to improve patient outcomes through their unique therapies, addressing unmet medical needs and enhancing the quality of life for patients with chronic conditions.

Key Details

Price

$5.42

Annual Revenue

$333.62 M(+168.06% YoY)

Annual EPS

-$0.17(+43.33% YoY)

Annual ROE

-23.01%

Beta

1.13

Events Calendar

Earnings

Next earnings date:

May 2, 2025

Recent quarterly earnings:

Feb 20, 2025

Recent annual earnings:

Feb 20, 2025
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Jul 20, 2021

Analyst ratings

Recent major analysts updates

Feb 21, 25 Raymond James
Strong Buy
Feb 21, 25 HC Wainwright & Co.
Neutral
Jan 27, 25 Piper Sandler
Neutral
Jan 16, 25 HC Wainwright & Co.
Neutral
Jan 2, 25 Jefferies
Buy
Nov 11, 24 HC Wainwright & Co.
Neutral
Nov 4, 24 Citigroup
Buy
Nov 1, 24 HC Wainwright & Co.
Buy
Aug 5, 24 HC Wainwright & Co.
Buy
Aug 2, 24 Wedbush
Outperform

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Ardelyx?
  • Does Ardelyx pay dividends?
  • What sector is Ardelyx in?
  • What industry is Ardelyx in?
  • What country is Ardelyx based in?
  • When did Ardelyx go public?
  • Is Ardelyx in the S&P 500?
  • Is Ardelyx in the NASDAQ 100?
  • Is Ardelyx in the Dow Jones?
  • When was Ardelyx's last earnings report?
  • When does Ardelyx report earnings?
  • Should I buy Ardelyx stock now?

What is the ticker symbol for Ardelyx?

The ticker symbol for Ardelyx is NASDAQ:ARDX

Does Ardelyx pay dividends?

No, Ardelyx does not pay dividends

What sector is Ardelyx in?

Ardelyx is in the Healthcare sector

What industry is Ardelyx in?

Ardelyx is in the Biotechnology industry

What country is Ardelyx based in?

Ardelyx is headquartered in United States

When did Ardelyx go public?

Ardelyx's initial public offering (IPO) was on June 19, 2014

Is Ardelyx in the S&P 500?

No, Ardelyx is not included in the S&P 500 index

Is Ardelyx in the NASDAQ 100?

No, Ardelyx is not included in the NASDAQ 100 index

Is Ardelyx in the Dow Jones?

No, Ardelyx is not included in the Dow Jones index

When was Ardelyx's last earnings report?

Ardelyx's most recent earnings report was on Feb 20, 2025

When does Ardelyx report earnings?

The next expected earnings date for Ardelyx is May 2, 2025

Should I buy Ardelyx stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions